United States · Seed startup

Who invested in Erg Bio

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Chemicals & Materials

Raised 12 months ago

Funding summaryUpdated 26 Oct 2026

$6.5Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $6.5MNov 2025
Investors
2
See who backed them

The rounds

  1. Nov 2025

Founders and team

From Erg Bio's own website: 4 on the team.

  • Vineet RajgarhiaCEO
  • Blake SimmonsCTO
  • Sabina WilsonChief of Staff
  • Chuck MateerDirector of Business Development

AdvisersMichael Rabson

Everyone who backed them

Plug and PlayAccelerator1round
Chevron Technology VenturesCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Erg Bio as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Azolla VenturesVC firmPer its own site
JuniperVC firmPer its own site
Lichen VenturesVC firmPer its own site

Quick answers about Erg Bio

Who invested in Erg Bio?

Erg Bio's investors include Plug and Play and Chevron Technology Ventures.

How much has Erg Bio raised?

Erg Bio has raised $6.5M across 1 round since 2025.

When did Erg Bio last raise?

Erg Bio's most recent round was a Seed of $6.5M in Nov 2025.

What was Erg Bio's biggest round?

Its most recent round, $6.5M in Nov 2025, is also its largest on record.

Who backed Erg Bio first?

Erg Bio's first round on record, in Nov 2025, was backed by Plug and Play and Chevron Technology Ventures.

What stage is Erg Bio at?

Erg Bio's latest named round is a Seed, in Nov 2025.

Where is Erg Bio based?

Erg Bio is based in the United States.

Companies like Erg Bio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.